ScreenerHero

PHOPhotocure ASA

OSL · NO · Healthcare · Drug Manufacturers - Specialty & Generic · photocure.com
54.10NOK0.00%Mkt Cap: 136.12M $P/E: 18.59

Photocure ASA, together with its subsidiaries, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products. It operates through two segments, Commercial Franchise and De…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
MERCK Kommanditgesellschaft auf Aktien
$65.19BUSDP/E 23.7
TAK
Takeda Pharmaceutical Co. Ltd.
$58.06BUSD
HLN
Haleon plc American Depositary Shares (Each representing two Ordinary Shares)
$43.98BUSDP/E 20.4
TEVA
Teva Pharmaceutical Industries Limited
$43.51BUSDP/E 62.2
ZOE
Zoetis Inc.
$29.89BUSDP/E 12.7
ZTS
Zoetis Inc.
$32.12BUSDP/E 12.7
UTHR
United Therapeutics Corporation
$22.01BUSDP/E 18.4
VTRS
Viatris, Inc.
$18.75BUSD
SOBI
Swedish Orphan Biovitrum AB
$15.34BUSDP/E 117.3
IPN
Ipsen S.A.
$14.67BUSDP/E 26.4
NBIX
Neurocrine Biosciences, Inc.
$15.51BUSDP/E 22.3
ELAN
Elanco Animal Health Incorporat
$11.98BUSD
RDY
Dr. Reddy's Laboratories Ltd
$10.15BUSDP/E 29.7
KRK
Krka, d. d.
$8.66BUSDP/E 19.0
ALKS
Alkermes plc
$8.11BUSDP/E 127.2
HIMS
Hims & Hers Health, Inc.
$7.88BUSD
LNTH
Lantheus Holdings Inc
$6.53BUSDP/E 23.9
AMRX
Amneal Pharmaceuticals, Inc. Class A
$6.24BUSDP/E 37.3
LQDA
Liquidia Corporation
$6.14BUSDP/E 49.0
KNSA
Kiniksa Pharmaceuticals, Ltd.
$6.08BUSDP/E 79.8

Key Statistics

Company
Market Cap136.12M $
Enterprise Value121.82M $
Revenue (TTM)63.45M $
Gross Profit45.86M $
Net Income (TTM)-141.81K $
Revenue/Share2.371 USD
Last Price54.10 NOK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees99
CountryNO
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)18.59
P/E (Forward)37.05
PEG14.90
EV/EBITDA10.05
EV/Revenue1.92
P/S2.15
P/B2.40
EPS (TTM)2.91
EPS (Forward)1.46
52W Range
46.2523% of range79.80
52W High79.80 NOK
52W Low46.25 NOK
Profitability
Gross Margin92.12%
Oper. Margin-6.59%
EBITDA Margin19.11%
Profit Margin-0.28%
ROE-0.31%
ROA-0.21%
Growth
Revenue Growth5.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF2.96M $
CapEx (TTM)2.03M $
FCF Margin1.86%
FCF Yield0.87%
Net Debt-14.30M $
Net Debt/EBITDA-1.18
Balance Sheet
Debt/Equity0.02
Current Ratio3.65
Quick Ratio3.11
Book Value/Sh22.54 NOK
Cash/Share6.034 NOK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 NOK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateMay 23, 2013
Pay Date—
Analyst Consensus
Rating—
Target (Mean)79.67 NOK
Upside (mean)+47.3%
Target Range75.00 NOK – 85.00 NOK
NOK75.00+47.3% to meanNOK85.00
# Analysts3
Ownership
Shares Out.26.92M
Float20.33M
Insiders3.58%
Institutions38.00%
Technical
SMA 5056.71 (-4.6%)
SMA 20063.28 (-14.5%)
Beta0.34
S&P 52W Chg19.18%
Avg Vol (30d)84.88K
Avg Vol (10d)121.61K
Technical Indicators
RSI (14)47.1
MACD-0.6385
MACD Signal-1.0815
MACD Hist.+0.4431
BB Upper58.51 NOK
BB Middle53.63 NOK
BB Lower48.75 NOK
BB Width18.19%
ATR (14)2.026 NOK
Vol Ratio (20d)0.56x